{"database": "lobbying", "table": "lobbying_activities", "rows": [[2821452, "57b4971e-430e-4cff-aa6b-786e11e1e783", "Q2", "REINECKE STRATEGIC SOLUTIONS, INC.", 298012, "PHARMAVITE LLC", 2022, "second_quarter", "CSP", "Regulation of dietary supplements and natural products. Specifically related to mandatory product listing and increased authority for FDA to combat illegal supplements. S. 1698 and H.R. 841 to provide for regulation of CBD products. S.4090, Dietary Supplement Listing Act. S. 4348, FDASLA Act of 2022. SHOP SAFE Act H.R. 3429/S.1843. INFORM Consumers Act S. 936. America Competes Act of 2022, H.R. 4521.", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2022-07-15T21:49:12-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2821452"], "units": {}, "query_ms": 39.48885400313884, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}